Skip to content

Jose Quiroz

Jose

Bow Therapeutics

2018-2019

Affiliations

Albert Einstein College of Medicine

Technologies

Therapeutic

Indication

Autoimmune & Inflammation

Drug Discovery

Human Monoclonal Antibodies

Infectious Disease

Executive Summary

View/Download

Bow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology.

Newsletter Signup

Corporate Supporters

Community Service Providers